Nachrichten zur Moderna Inc. Aktie

Moderna shares slip premarket as analysts cut ratings amid guidance worries By Investing.com

Moderna shares slip premarket as analysts cut ratings amid guidance worries…

MRNA Stock Falls 12% on Lowered Sales Outlook, R&D Budget Cuts

As part of its strategic prioritization, Moderna aims to cut its R&D expenses by 20% over the next four years.…

Moderna is dialing back its vaccine ambitions

It came to the rescue during the pandemic, but the pharmaceutical industry is a what-have-you-done-for-me-lately business.…

Stock Market Today: Stocks Rise in Choppy Day for Markets

Moderna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.…

Moderna cites 2025 launch for Merck partnered cancer vaccine: report

…

Nvidia, August PPI and jobless claims ahead of Fed cut: Morning Brief

US stocks were mixed heading into Thursdays session, with the S&P 500 (^GSPC) and Nasdaq Composite (^IXIC) up, extending Wednesday’s…

Stocks making the biggest moves midday: Kroger, Petco, Moderna, Roku and more

These are the stocks posting the largest moves in midday trading.…

AKTIE IM FOKUS: Trister Umsatzausblick schickt Moderna auf Talfahrt

NEW YORK (dpa-AFX) - Die Aktien des Impfstoffherstellers Moderna sind am Donnerstag nach einem mit…

Moderna: Fresh Sell-Off On Cost Cutting Initiatives, Short-Term Outlook Troubling

…

Nvidia, Alaska Air higher premarket; Moderna slips By Investing.com

Nvidia, Alaska Air higher premarket; Moderna slips…

Stocks making the biggest moves premarket: Moderna, Alaska Air, Oxford Industries and more

These are the stocks posting the largest moves in early trading.…

Moderna shares drop after cutting research budget By Investing.com

Moderna shares drop after cutting research budget…

Moderna shares tank after announcing $1.1bn cost-cutting measures

US pharmaceuticals giant Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares tanked more than 17% on Thursday after announcing a $1.2 billion cost-cutting…

Moderna Slashes Research Budget as Vaccine Sales Disappoint

(Bloomberg) -- Moderna Inc. aims to reduce its research and development budget by about 20% over the next three years…

Moderna expects up to $3.5 billion in 2025 sales By Reuters

Moderna expects up to $3.5 billion in 2025 sales…

Moderna to cut $1.1 billion in costs and launch 10 new products by 2027 as it charts post-Covid future

Moderna is deprioritizing certain parts of its pipeline, which involves pausing work on some products and scrapping others.…

Moderna Slashes Research Budget as Vaccine Sales Disappoint

Moderna Inc. aims to reduce its research and development budget by about 20% over the next three years as the…

Nasdaq, Wall Street open flat as Moderna tumbles

9.55am: Moderna tumbles US markets opened flat today despite pre-market trades pointing to a relatively well-bid opening session. The Nasdaq…

October 8, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against MRNA

NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

New Updated Covid-19 Vaccines Are Available. When Should You Get It?

The newest, updated Covid-19 vaccines are now FDA-approved and available including the mRNA ones from Pfizer-BioNTech and Moderna and the…

MRNA Gets Positive CHMP Opinion for Updated COVID-19 Jab

The Committee for Medicinal Products for Human Use recommends marketing authorization for Modernas updated mRNA COVID-19 jab, Spikevax.…

Moderna, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MRNA

NEW YORK, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Moderna, Inc. ("Moderna"…

Moderna Aktie: Neue Impfstoffzulassung im Fokus

Positiver Ausblick für die Herbst-/Wintersaison Moderna hat einen bedeutenden Schritt Richtung Zulassung seines weiterentwickelten COVID-19-mRNA-Impfstoffs für die Impfsaison 2024/2025 gemacht, da…

IRW-News: Moderna Inc.: Ausschuss für Humanarzneimittel der EMA gibt positive Stellungnahme ab und empfiehlt Zulassung von Modernas COVID-19-mRNA-Impfstoff, der gegen die SARS-COV-2-Variante JN.1 gerichtet ist

IRW-PRESS: Moderna Inc.: Ausschuss für Humanarzneimittel der EMA gibt positive Stellungnahme ab und empfiehlt Zulassung von Modernas COVID-19-mRNA-Impfstoff, der gegen…

IRW-News: Moderna Inc.: Ausschuss für Humanarzneimittel der EMA gibt positive Stellungnahme ab und empfiehlt Zulassung von Modernas COVID-19-mRNA-Impfstoff, der gegen die SARS-COV-2-Variante JN.1 gerichtet ist

IRW-PRESS: Moderna Inc.: Ausschuss für Humanarzneimittel der EMA gibt positive Stellungnahme ab und empfiehlt Zulassung von…

Moderna, Inc. Shareholders - Robbins LLP Reminds MRNA Stockholders of the Class Action Lawsuit Against the Company – Seek Counsel Today

Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine…

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline…

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

NEW YORK, Sept. 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Street Calls of the Week: Moderna upgraded, downgrade for Hershey By Investing.com

Street Calls of the Week: Moderna upgraded, downgrade for Hershey…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm

NEW YORK, Aug. 30, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

FDA authorizes Novavax’s updated Covid vaccine, paving way for fall rollout

The decision comes only a week after it approved a new round of messenger RNA shots from Pfizer and Moderna,…

Moderna: HSBC stuft die Aktie aufgrund des großen Potenzials des Krebsimpfstoffs hoch - Aktienanalyse

London (www.aktiencheck.de) - Moderna-Aktienanalyse von HSBC: Die Analysten von HSBC stufen die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol:…

Moderna stock gains on HSBC upgrade, despite ongoing concerns By Investing.com

Moderna stock gains on HSBC upgrade, despite ongoing concerns…

Here are Wednesdays biggest analyst calls: Nvidia, Apple, Meta, Tesla, McDonalds, Moderna & more

Here are Wednesdays biggest calls on Wall Street.…

INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Moderna, Inc. (NASDAQ: MRNA); Investors with Losses Encouraged to Discuss Their Options with Counsel

SAN DIEGO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of…

Healthy Returns: What to know about the latest round of Pfizer, Moderna Covid vaccines

A brand new round of Covid shots from Pfizer and Moderna is about to reach Americans. Meanwhile, CNBC tested out…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm

NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

Modernas Vaccine Progress Undermined By RSV Market Contraction (Rating Downgrade)

…

09:15: Moderna: Bodenbildung nach Kurseinbruch!

Die Coronapandemie ist noch leicht am Köcheln und könnte weiter für Umsätze bei Moderna sorgen. Aber es sind noch weitere…

Moderna mit enttäuschendem Auftritt. Montag wird richtig wichtig.

Zahlreiche Nackenschläge mussten zuletzt die Anteilseigner von Moderna hinnehmen. Schließlich gab der Kurs im Verhältnis zur Vorwoche 8,48 Prozent nach.…

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

NEW YORK, Aug. 24, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

ROSEN, LEADING INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA

NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, PDD Holdings, Extreme Networks, and Sprinklr and Encourages Investors to Contact the Firm

NEW YORK, Aug. 20, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

dpa-AFX ProFeed